StonvexLoading…
StonvexStonvexStonvexReal-time TradingView chart with full indicator set.
Last 7 days, powered by Finnhub. Tap Analyze to classify direction.
Loading latest news…
Pick the depth your tier unlocks. Logged-in Pro/Premium users automatically get the deeper report.
Free preview · 3 reports / hour · No sign-up required
Factor grades, AI Copilot, personalized ranking, and deeper event analysis.
Upgrade to Pro →Share this analysis with other traders
Disclaimer: The content on this page is for informational and educational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any security. Past performance does not guarantee future results. Consult a licensed financial advisor before making any investment decisions.
No sell-side coverage available for VYCO yet.
Common for small-cap names, ETFs, recent IPOs, and ADRs without US-listed sell-side coverage. When analysts publish, ratings appear here within one business day.
| Date | Open | Close | Δ | Vol |
|---|---|---|---|---|
| 04-22 | $0.06 | $0.07 | +15.73% | 0.0M |
| 04-24 | $0.05 | $0.07 | +36.99% | 0.0M |
| 04-28 | $0.05 | $0.07 | +34.61% | 0.0M |
| 05-08 | $0.07 | $0.07 | +0.00% | 0.0M |
| 05-22 | $0.06 | $0.07 | +11.04% | 0.0M |
Indicator values from Polygon. Educational only — single- indicator triggers in isolation are not a complete trading signal.
VYCOR MEDICAL INC
Fundamentals not available for VYCO yet.
We pull from FMP, Finnhub, and Polygon — common gaps are very recent IPOs that haven't filed their first 10-Q, pink-sheet OTC tickers, and foreign filers without US-listed depth. The Financials tab reads SEC EDGAR directly and may still have data here.
Documents are served directly from sec.gov / the issuer's website — Stonvex does not proxy or store filings.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $458.54K | $1.86M | $1.45M | $932.73K |
Operating Income | $45.81K | $33.90K | $70.42K | $38.34K |
Net Income | $20.11K | $-72.43K | $-9.74K | $-14.68K |
EPS (Diluted) | $0.00 | $-0.01 | $-0.01 | $-0.01 |
Total Assets | $854.07K | $830.42K | $941.20K | $878.95K |
Total Liabilities | $5.08M | $4.92M | $4.97M | $4.75M |
Cash & Equivalents | $173.63K | $86.98K | $64.23K | $99.70K |
Free Cash Flow OCF − CapEx | Not available | $-18.70K | $-56.32K | $16.11K |
Shares Outstanding | 33.37M | 33.37M | 33.37M | 33.37M |